
Elpip 4000mg/500mg Injection
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Elpip 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by a physician based on individual illness severity. Strict adherence to prescribed usage is crucial. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver impairments to your doctor, who may adjust the dosage or recommend an alternative. Under medical guidance, this injection is generally deemed safe for pregnant and breastfeeding individuals.
Uses of Elpip 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Elpip 4000mg/500mg Injection:
Administering this medication will be handled by your physician or their designated nurse; please refrain from self-medication.
Common Side effects of Elpip 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Elpip 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Elpip 4000mg/500mg Injection works:
Elpip Injection, containing 4000mg of piperacillin and 500mg of tazobactam, combines an antibiotic with a resistance-modifying agent. Piperacillin's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Elpip 4000mg/500mg Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Elpip, 4000mg/500mg, is typically regarded as safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Elpip, 4000mg/500mg, presents a low risk to breastfeeding infants. Research in human subjects indicates minimal drug transfer to breast milk, posing no discernible threat to the nursing child.
DrivingCONSULT YOUR DOCTOR
The effect of Elpip 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Elpip 4000mg/500mg Injection requires careful consideration. Dosage modification of Elpip 4000mg/500mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Elpip 4000mg/500mg Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dose modification may be unnecessary for this patient population. However, medical advice is recommended.
What if you forget to take Elpip 4000mg/500mg Injection :
Should you forget a scheduled dose of Elpip 4000mg/500mg Injection, seek medical advice.
Facts to Know About Elpip 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
